661 Results for "

Jacobaea cannabifolia (Less.) E. Wiebe

" in MedChemExpress (MCE) Product Catalog:
Products (661)

661 Results for "Jacobaea cannabifolia (Less.) E. Wiebe" in MCE Product Catalog:

251
251 Publications Verification
Cat. No.: HY-15531
CAS No.: 1257044-40-8
Pureté:  99.95%
Synonyms: ABT-199; GDC-0199; RG7601
Target:  

Bcl-2 Family Autophagy

Domaines de recherche:  

Cancer

Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM. Venetoclax induces autophagy .
loading...
    loading...
177
177 Cited Publications
Cat. No.: HY-13205
CAS No.: 273404-37-8
Pureté:  99.99%
Synonyms: VX-765
Target:  

Caspase

Domaines de recherche:  

Inflammation/Immunology

Belnacasan (VX-765) is an orally bioactive proagent of VRT-043198, which is a potent and selective inhibitor of IL-converting enzyme (ICE)/caspase-1 with Kis of 0.8 nM and less than 0.6 nM for caspase-1 and caspase-4, respectively. Belnacasan (VX-765) inhibits the release of LPS-induced IL-1β and IL-18 by human PBMCs with an IC50 of ~0.7 μM .
loading...
    loading...
158
158 Cited Publications
Cat. No.: HY-10087
CAS No.: 923564-51-6
Pureté:  99.72%
Synonyms: ABT-263
Target:  

Bcl-2 Family

Domaines de recherche:  

Cancer

Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2 and Bcl-w, with a Ki of less than 1 nM .
loading...
    loading...
97
97 Cited Publications
Cat. No.: HY-13823
CAS No.: 328968-36-1
Pureté:  99.88%
C646 is a selective and competitive histone acetyltransferase p300 inhibitor with Ki of 400 nM, and is less potent for other acetyltransferases .
loading...
    loading...
84
84 Cited Publications
Cat. No.: HY-15777
CAS No.: 1211441-98-3
Pureté:  99.94%
Synonyms: LEE011
Target:  

CDK

Domaines de recherche:  

Neurological Disease Cancer

RRibociclib (LEE011) is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
84
84 Cited Publications
Cat. No.: HY-15777A
CAS No.: 1211443-80-9
Pureté:  99.93%
Synonyms: LEE011 hydrochloride
Target:  

CDK

Domaines de recherche:  

Neurological Disease Cancer

RRibociclib (LEE011) hydrochloride is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
84
84 Cited Publications
Cat. No.: HY-15777B
CAS No.: 1374639-75-4
Pureté:  99.93%
Synonyms: LEE011 succinate
Target:  

CDK

Domaines de recherche:  

Neurological Disease Cancer

RRibociclib (LEE011) succinate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
84
84 Cited Publications
Cat. No.: HY-15777C
CAS No.: 1374639-79-8
Pureté:  99.94%
Synonyms: LEE011 succinate hydrate
Target:  

CDK

Domaines de recherche:  

Cancer

RRibociclib (LEE011) succinate hydrate is an ATP-competitive and orally active CDK4/6 inhibitor that crosses the blood-brain barrier with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex .
loading...
    loading...
63
63 Cited Publications
Cat. No.: HY-15145A
CAS No.: 2468639-77-0
Pureté:  99.19%
Target:  

Sirtuin Autophagy

Domaines de recherche:  

Metabolic Disease

SRT 1720 dihydrochloride is a selective and orally active activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3 .
loading...
    loading...
63
63 Cited Publications
Cat. No.: HY-15145
CAS No.: 2060259-60-9
Pureté:  99.37%
Target:  

Sirtuin Autophagy

Domaines de recherche:  

Metabolic Disease

SRT 1720 monohydrochloride is a selective and orally active activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and SIRT3 .
loading...
    loading...
63
63 Cited Publications
Cat. No.: HY-10532
CAS No.: 925434-55-5
Pureté:  99.90%
Target:  

Sirtuin Autophagy

Domaines de recherche:  

Metabolic Disease

SRT 1720 is a selective activator of human SIRT1 with an EC1.5 of 0.16 μM, and shows less potent activities for SIRT2 and SIRT3 with EC1.5s of 37 μM and > 300 μM, respectively.
loading...
    loading...
56
56 Cited Publications
Cat. No.: HY-19741
CAS No.: 1430844-80-6
Target:  

Bcl-2 Family

Domaines de recherche:  

Cancer

A-1331852 is an orally available BCL-XL selective inhibitor with a Ki of less than 10 pM.
loading...
    loading...
55
55 Cited Publications
Cat. No.: HY-12867
CAS No.: 1672665-49-4
Pureté:  99.95%
Domaines de recherche:  

Cancer

PT-2385 is a selective HIF-2α inhibitor with a Ki of less than 50 nM .
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-16591
CAS No.: 1260251-31-7
Synonyms: TL32711
Target:  

IAP Apoptosis HIV

Domaines de recherche:  

Cancer

Birinapant (TL32711), a bivalent Smac mimetic, is a potent antagonist for XIAP and cIAP1 with Kds of 45 nM and less than 1 nM, respectively. Birinapant (TL32711) induces the autoubiquitylation and proteasomal degradation of cIAP1 and cIAP2 in intact cells, which results in formation of a RIPK1: caspase-8 complex, caspase-8 activation, and induction of tumor cell death. Birinapant (TL32711) targets TRAF2-associated cIAPs and abrogates TNF-induced NF-κB activation.
loading...
    loading...
36
36 Cited Publications
Cat. No.: HY-109015
CAS No.: 1616493-44-7
Pureté:  98.60%
Synonyms: Chidamide; HBI-8000; CS 055
Target:  

HDAC

Domaines de recherche:  

Cancer

Tucidinostat (Chidamide) is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8 and HDAC11 (IC50s, 733 nM, 432 nM, respectively), and shows no effect on HDAC4/5/6/7/9 .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-101570
CAS No.: 1637542-33-6
Pureté:  99.70%
Synonyms: Peposertib; M3814
Target:  

DNA-PK BCRP

Domaines de recherche:  

Cancer

Nedisertib (Peposertib) is an orally active selective DNA-dependent protein kinase (DNA-PK) inhibitor with an IC50 value of less than 3 nM. Nedisertib also acts as a modulator of ABCG2, capable of reversing ABCG2-mediated multidrug resistance (MDR), thus providing new strategies for combination therapy. By inhibiting DNA double-strand break repair, Nedisertib can enhance the efficacy of chemotherapy and radiotherapy. Nedisertib exhibits antitumor activity .
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-16671
CAS No.: 307510-92-5
Target:  

CFTR Autophagy

Domaines de recherche:  

Others

CFTR(inh)-172 is a potent and selective blocker of the CFTR chloride channel; reversibly inhibits CFTR short-circuit current in less than 2 minutes with a Ki of 300 nM.
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-17628
CAS No.: 1225208-94-5
Synonyms: S-649266
Target:  

Bacterial Antibiotic

Domaines de recherche:  

Infection

Cefiderocol (S-649266) is a siderophore cephalosporin which has a potent activity against a broad range of aerobic Gram-negative bacterial species with MIC50s of 2 μg/mL or less.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-10961
CAS No.: 1056634-68-4
Pureté:  99.37%
Synonyms: CYT387
Target:  

JAK Autophagy Apoptosis

Domaines de recherche:  

Cancer

Momelotinib (CYT387) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50a of 11 nM and 18 nM,respectively. CYT387 shows much less activity against JAK3.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-13863
CAS No.: 1256493-34-1
Pureté:  99.11%
Synonyms: Dyngo-4a
Target:  

Dynamin

Domaines de recherche:  

Neurological Disease

Hydroxy Dynasore (Dyngo-4a), a structural mimetic analog of Dynasore (HY-15304), is an improved, less cytotoxic and versatile dynamin inhibitor with IC50 values ​​of 0.38 μM and 2.3 μM for brain recombinant dynamin I and recombinant mouse dynamin II, respectively. Hydroxy Dynasore inhibits dynamin-dependent transferrin endocytosis with an IC50 of 5.7 μM.
loading...
    loading...